Institutions added 4.4% to their holdings in the quarter ending June 2026 (5 bought, 8 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$3.94+0.3% that day
Company value
$29M
Share price times all shares
Price vs sales
0.19x
No profit over the last year, so this compares value with sales instead
Cash vs value
18%
Cash as a share of company value
From HHS's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26
$38.0M-1.7% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $154.6M, down 12% from the 12 months before. Over 5 years, sales shrank about 2.0% a year.
What the price assumes
Your guesses, our math
Move the sliders to your own view of HHS. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
Sales in 5 years$91M
Profit in 5 years$9M
Price these guesses point to$18.37+366% vs $3.94 todayAbout +36% a year, before dividends
What today's price needs: with a 10% margin and a 15x P/E, sales could shrink about 34% a year for 5 years and still match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
The checklist Warren Buffett-style investors use. Annual numbers for 2025.
1/5Weak
MissReturn on equity 15%+Earns a lot on the money owners have in the business.-3.8%
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-0.5%
MissProfitable every yearSteady profits, not one good year.2 of 10 years
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$4.5M
PassShare count not growingNot diluting owners. Falling means buybacks.-0.9% in 3 years
Revenue
$159.6M
-13.9% vs prior year
5-year growth
-2.0%/yr
revenue, per year
Current ratio
1.54x
short-term assets / bills due
Free cash flow
-$4.5M
-2.8% of revenue
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: debt under half of equity, gross margin 40%+. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026
Reported May 14
Revenue
$38.0M
-1.7% YoY
EPS
-$0.67
vs -$0.05
Op. margin
-11.8%
-11.9 pts
Free cash flow
-$2.0M
Share count
+0.7%
vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trend
No trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
This week
0
Normal week
0.4
vs normal
0.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
■Steady+4.4%
Institutions added 4.4% to their holdings. 5 bought, 8 sold. 2 quarters of net buying in a row.
Shares held by institutions2.2M
Sep '24Jun '26
Safety check
From SEC filings
Share count growthYearly rate, last 3 years
+1.1%
Cash runwayAt last year's cash burn
36 months
Debt to equityLatest balance sheet: debt compared with what owners have
Total liabilities $72.7M
Shares outstandingLatest reported
7M
Why moderate risk
Losing money
Revenue down 13.9% from the year before
Earnings reports
Last 12
Next reportDue any dayEstimated from the same quarter last year
Results filedMay 14
Results filedMar 18
Results filedNov 10, 2025
Results filedAug 7, 2025
Results filedMay 14, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days